Literature DB >> 20021507

Use and abuse of faecal occult blood tests in an acute hospital inpatient setting.

A Friedman1, A Chan, L C Chin, A Deen, G Hammerschlag, M Lee, J Liddell, K Loh, E Moore, J Ng, P R Gibson.   

Abstract

BACKGROUND/AIMS: The role of the faecal occult blood test (FOBT) is untested. The aims of this study were to define the use of FOBT in a general hospital setting and to determine its influence on patient management.
METHODS: Case notes and laboratory reports were retrospectively reviewed in all FOBTs performed in 2006 across three acute hospitals, with specific reference to clinical setting, indication, influence over clinical decision-making and management. Both guaiac and immunological tests were performed on all specimens.
RESULTS: A total of 330 patients aged 2-104 (mean 74) years, 47% men, had 461 tests performed. A positive result was recorded in one or both tests in 64% of patients. Evidence of dietary restriction was found in only eight (2%) of patients and 218 (66%) patients took one or more medications that could have caused a false positive result. Indications were mostly for overt or suspected gastrointestinal blood loss with or without anaemia and/or iron deficiency, but 5% were for non-bloody diarrhoea and 3% screening for colorectal cancer. Patient care was adversely affected or delayed in 54 patients (16%), mostly because of the result being the stimulus for the decision to refer or not for endoscopy. Only one was considered appropriate as a screening test for colorectal cancer.
CONCLUSIONS: The FOBT was applied in clinically inappropriate settings without consideration to confounding issues, and often led to inappropriate clinical decisions with considerable cost to hospital and patient. There is no place for FOBT in an acute hospital setting.

Entities:  

Mesh:

Year:  2009        PMID: 20021507     DOI: 10.1111/j.1445-5994.2009.02149.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  8 in total

1.  Use of fecal occult blood testing in hospitalized patients: results of an audit.

Authors:  Stephen Ip; AbdulRazaq A H Sokoro; Lisa Kaita; Claudia Ruiz; Elaine McIntyre; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2014-10

2.  Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign.

Authors:  Elisa Stasi; Andrea Michielan; Gaetano Cristian Morreale; Alessandro Tozzi; Ludovica Venezia; Francesco Bortoluzzi; Omero Triossi; Marco Soncini; Gioacchino Leandro; Giuseppe Milazzo; Andrea Anderloni
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

3.  A Case for Abandoning Inpatient Fecal Occult Blood Testing.

Authors:  Gregory T Brennan; Andrew S Parsons
Journal:  Cureus       Date:  2020-06-24

4.  Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.

Authors:  Neeraj Narula; Diana Ulic; Raed Al-Dabbagh; Ali Ibrahim; Maged Mansour; Cynthia Balion; John K Marshall
Journal:  Can J Gastroenterol Hepatol       Date:  2014-07-11

5.  Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists.

Authors:  Stephen Ip; AbdulRazaq A H Sokoro; Al Buchel; Debrah Wirtzfeld; Gerald Konrad; Tunji Fatoye; Harminder Singh
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

6.  Utilization of fecal occult blood test in the acute hospital setting and its impact on clinical management and outcomes.

Authors:  S Mosadeghi; H Ren; J Catungal; I Yen; B Liu; R J Wong; T Bhuket
Journal:  J Postgrad Med       Date:  2016 Apr-Jun       Impact factor: 1.476

7.  Irritable bowel syndrome diagnosis.

Authors:  Nick Tyllis
Journal:  Aust Prescr       Date:  2019-06-03

8.  Use and abuse of fecal occult blood tests: a community hospital experience.

Authors:  Sarthak Soin; Olalekan Akanbi; Abdullah Ahmed; Yunha Kim; Sarbagya Pandit; Igor Wroblewski; Nasir Saleem
Journal:  BMC Gastroenterol       Date:  2019-09-03       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.